Hematologic Malignancies
News
High cost and demand for old cancer drug sparks crisis
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
Latest News
Pandemic caused treatment delay for half of patients with CTCL, study finds
No clinical trials exist to inform maintenance protocols in patients with cutaneous lymphomas.
News
Blenrep for multiple myeloma withdrawn from U.S. market
As requested by the U.S. Food and Drug Administration, the multiple myeloma drug blenrep is being taken off the market after disappointing results...
News
CAR T-cell therapy neurotoxicity linked to NfL elevations
Even prior to CAR T-cell therapy, patients developing related neurotoxic complications show elevated markers of neuronal injury.
News
Drug combo holds promise of better AML outcomes
Study suggests that the venetoclax-gilteritinib drug combination “potentially improves response frequency and depth.”
Article
From B to T: a Case of Concurrent B-Cell and T-Cell Lymphomas Successfully Palliated With Targeted Therapies
Article
Impact of Pharmacist-Driven Telemedicine Services in Hematopoietic Stem Cell Transplant (HSCT) Long-term Care Clinic in a Veteran Population
Article
Evaluating the Incidence of Febrile Neutropenia and the Appropriate Use of Prophylactic Granulocyte Colony Stimulating Factors in Veterans Who Received Treatment for Non- Hodgkin’s Lymphoma
Article
A Rare Case of HHV8+ Multicentric Castleman Disease Presenting as Dermatitis
Original Research
Agent Orange Exposure, Transformation From MGUS to Multiple Myeloma, and Outcomes in Veterans
This study explored variation in survival related to Agent Orange exposure, transformation from MGUS to multiple myeloma, and survival as a...